Literature DB >> 2858506

Description of phenotypically distinct T-lymphocyte subsets which mediate helper/DTH and cytotoxic functions in the Syrian hamster.

P L Witte, J Stein-Streilein, J W Streilein.   

Abstract

Recent studies describe aberrations in the functions of T lymphocytes from Syrian hamsters. A current proposal links the apparent functional deficiencies of cytotoxic and suppressor T cells with anomalies found in class I molecules of this species (no polymorphism is detected) and speculates that hamsters possess limited heterogeneity of T cell subpopulations, particularly a class I-restricted subset. The present work tests this hypothesis by examining the extent of T cell heterogeneity defined by differential cell surface antigen expression. A panel of mouse monoclonal antibodies against hamster lymphocyte antigens was generated. MAb #20 and #110 bound to most, if not all, peripheral T cells; a third antibody, #38, divided T cells into two subpopulations which were functionally distinct. Cells within the #38-negative subset produced easily detectable IL 2 and mediated delayed-type hypersensitivity to influenza virus. In contrast, isolated 38+ cells produced little IL 2 and required the addition of exogenous T cell growth factor for proliferation to Con A. Treatment of immune cells with mAb #38 and complement abrogated cytolysis to TNP-haptenated or influenza-infected targets. Thus, Syrian hamsters possess at least two T cell subpopulations of discrete functional ability and unique cell surface antigen expression. Although the data suggest that T cells analogous to those of the class I-restricted, Lyt 2+ subset are present in the hamster, it is predicted that the scope of their composite antigen receptor repertoire may be limited by the monomorphism of class I molecules in this species.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858506

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters.

Authors:  B K Du Chateau; D M England; S M Callister; L C Lim; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.

Authors:  B K DuChateau; J R Jensen; D M England; S M Callister; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Immune T cells sorted by flow cytometry confer protection against infection with Treponema pallidum subsp. pertenue in hamsters.

Authors:  H Liu; B M Steiner; J D Alder; D K Baertschy; R F Schell
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi.

Authors:  J R Jensen; B K Du Chateau; E L Munson; S M Callister; R F Schell
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; R F Schell
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

6.  Role of L3T4+ and 38+ T-cell subsets in resistance against infection with Treponema pallidum subsp. pertenue in hamsters.

Authors:  H Liu; J D Alder; B M Steiner; J Stein-Streilein; L Lim; R F Schell
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

7.  Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.

Authors:  C Gifawesen; J P Farrell
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

8.  Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules.

Authors:  Jennifer Rees; David Haig; Victoria Mack; William C Davis
Journal:  Vet Immunol Immunopathol       Date:  2016-12-06       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.